BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 25477336)

  • 21. The Hedgehog signalling pathway mediates drug response of MCF-7 mammosphere cells in breast cancer patients.
    He M; Fu Y; Yan Y; Xiao Q; Wu H; Yao W; Zhao H; Zhao L; Jiang Q; Yu Z; Jin F; Mi X; Wang E; Cui Z; Fu L; Chen J; Wei M
    Clin Sci (Lond); 2015 Nov; 129(9):809-22. PubMed ID: 26201092
    [TBL] [Abstract][Full Text] [Related]  

  • 22. UDP-glucuronosyltransferase 1A6 overexpression in breast cancer cells resistant to methotrexate.
    de Almagro MC; Selga E; Thibaut R; Porte C; Noé V; Ciudad CJ
    Biochem Pharmacol; 2011 Jan; 81(1):60-70. PubMed ID: 20854796
    [TBL] [Abstract][Full Text] [Related]  

  • 23. N-glucuronidation of the platelet-derived growth factor receptor tyrosine kinase inhibitor 6,7-(dimethoxy-2,4-dihydroindeno[1,2-C]pyrazol-3-yl)-(3-fluoro-phenyl)-amine by human UDP-glucuronosyltransferases.
    Yan Z; Caldwell GW; Gauthier D; Leo GC; Mei J; Ho CY; Jones WJ; Masucci JA; Tuman RW; Galemmo RA; Johnson DL
    Drug Metab Dispos; 2006 May; 34(5):748-55. PubMed ID: 16455802
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combined action and regulation of phase II enzymes and multidrug resistance proteins in multidrug resistance in cancer.
    Meijerman I; Beijnen JH; Schellens JH
    Cancer Treat Rev; 2008 Oct; 34(6):505-20. PubMed ID: 18413281
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic and pharmacologic inhibition of eIF4E reduces breast cancer cell migration, invasion, and metastasis.
    Pettersson F; Del Rincon SV; Emond A; Huor B; Ngan E; Ng J; Dobocan MC; Siegel PM; Miller WH
    Cancer Res; 2015 Mar; 75(6):1102-12. PubMed ID: 25608710
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of mammalian target of rapamycin induces phosphatidylinositol 3-kinase-dependent and Mnk-mediated eukaryotic translation initiation factor 4E phosphorylation.
    Wang X; Yue P; Chan CB; Ye K; Ueda T; Watanabe-Fukunaga R; Fukunaga R; Fu H; Khuri FR; Sun SY
    Mol Cell Biol; 2007 Nov; 27(21):7405-13. PubMed ID: 17724079
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A recombinant phenobarbital-inducible rat liver UDP-glucuronosyltransferase (UDP-glucuronosyltransferase 2B1) stably expressed in V79 cells catalyzes the glucuronidation of morphine, phenols, and carboxylic acids.
    Pritchard M; Fournel-Gigleux S; Siest G; Mackenzie P; Magdalou J
    Mol Pharmacol; 1994 Jan; 45(1):42-50. PubMed ID: 8302279
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human inducible nitric oxide synthase (iNOS) expression depends on chromosome region maintenance 1 (CRM1)- and eukaryotic translation initiation factor 4E (elF4E)-mediated nucleocytoplasmic mRNA transport.
    Bollmann F; Fechir K; Nowag S; Koch K; Art J; Kleinert H; Pautz A
    Nitric Oxide; 2013 Apr; 30():49-59. PubMed ID: 23471078
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Eukaryotic initiation factor 4E variants alter the morphology, proliferation, and colony-formation properties of MDA-MB-435 cancer cells.
    Goldson TM; Vielhauer G; Staub E; Miller S; Shim H; Hagedorn CH
    Mol Carcinog; 2007 Jan; 46(1):71-84. PubMed ID: 17091471
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of eIF4E with ribavirin cooperates with common chemotherapies in primary acute myeloid leukemia specimens.
    Kraljacic BC; Arguello M; Amri A; Cormack G; Borden K
    Leukemia; 2011 Jul; 25(7):1197-200. PubMed ID: 21455212
    [No Abstract]   [Full Text] [Related]  

  • 31. eIF4E/4E-BP ratio predicts the efficacy of mTOR targeted therapies.
    Alain T; Morita M; Fonseca BD; Yanagiya A; Siddiqui N; Bhat M; Zammit D; Marcus V; Metrakos P; Voyer LA; Gandin V; Liu Y; Topisirovic I; Sonenberg N
    Cancer Res; 2012 Dec; 72(24):6468-76. PubMed ID: 23100465
    [TBL] [Abstract][Full Text] [Related]  

  • 32. UDP-glucuronosyltransferases and clinical drug-drug interactions.
    Kiang TK; Ensom MH; Chang TK
    Pharmacol Ther; 2005 Apr; 106(1):97-132. PubMed ID: 15781124
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic suppression of translation initiation factor eIF4E expression reduces tumor growth without toxicity.
    Graff JR; Konicek BW; Vincent TM; Lynch RL; Monteith D; Weir SN; Schwier P; Capen A; Goode RL; Dowless MS; Chen Y; Zhang H; Sissons S; Cox K; McNulty AM; Parsons SH; Wang T; Sams L; Geeganage S; Douglass LE; Neubauer BL; Dean NM; Blanchard K; Shou J; Stancato LF; Carter JH; Marcusson EG
    J Clin Invest; 2007 Sep; 117(9):2638-48. PubMed ID: 17786246
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reciprocal regulation of hypoxia-inducible factor 2α and GLI1 expression associated with the radioresistance of renal cell carcinoma.
    Zhou J; Wu K; Gao D; Zhu G; Wu D; Wang X; Chen Y; Du Y; Song W; Ma Z; Authement C; Saha D; Hsieh JT; He D
    Int J Radiat Oncol Biol Phys; 2014 Nov; 90(4):942-51. PubMed ID: 25585786
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Noncanonical regulation of the Hedgehog mediator GLI1 by c-MYC in Burkitt lymphoma.
    Yoon JW; Gallant M; Lamm ML; Iannaccone S; Vieux KF; Proytcheva M; Hyjek E; Iannaccone P; Walterhouse D
    Mol Cancer Res; 2013 Jun; 11(6):604-15. PubMed ID: 23525267
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Knockdown of eIF4E suppresses cell proliferation, invasion and enhances cisplatin cytotoxicity in human ovarian cancer cells.
    Wan J; Shi F; Xu Z; Zhao M
    Int J Oncol; 2015 Dec; 47(6):2217-25. PubMed ID: 26498997
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gli1 is a potential target for alleviating multidrug resistance of gliomas.
    Cui D; Xu Q; Wang K; Che X
    J Neurol Sci; 2010 Jan; 288(1-2):156-66. PubMed ID: 19818966
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sonic Hedgehog-dependent proliferation in a series of patients with colorectal cancer.
    Douard R; Moutereau S; Pernet P; Chimingqi M; Allory Y; Manivet P; Conti M; Vaubourdolle M; Cugnenc PH; Loric S
    Surgery; 2006 May; 139(5):665-70. PubMed ID: 16701100
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Emx2 homeodomain transcription factor interacts with eukaryotic translation initiation factor 4E (eIF4E) in the axons of olfactory sensory neurons.
    Nédélec S; Foucher I; Brunet I; Bouillot C; Prochiantz A; Trembleau A
    Proc Natl Acad Sci U S A; 2004 Jul; 101(29):10815-20. PubMed ID: 15247416
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ribavirin suppresses eIF4E-mediated oncogenic transformation by physical mimicry of the 7-methyl guanosine mRNA cap.
    Kentsis A; Topisirovic I; Culjkovic B; Shao L; Borden KL
    Proc Natl Acad Sci U S A; 2004 Dec; 101(52):18105-10. PubMed ID: 15601771
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.